Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Oxford PharmaGenesis

Website
Email
+44 (0)1865 390144

WHO are we? Founded in 1998, Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy providing communications services to the healthcare industry, professional societies and patient groups. We’re supporting clients globally with over 500 people, in offices and remotely, across Europe, North America and Asia-Pacific.

WHAT drives us? We are a team of passionate and experienced individuals wholly committed to helping our clients to accelerate adoption of evidence-based innovations for patients in areas of unmet medical need. We aim to employ only the very best people who share our vision for:

  • excellence in our thinking, our client service and our delivery of outstanding communications
  • real enjoyment of our work, because we know that we are making a difference in the world
  • dedication and professionalism in everything we do.

WHY are we different? We understand that our clients are people, and we know that we can be successful by helping them to be successful – by listening, by advising and by being outstandingly good at what we do, wherever it’s needed, whenever it’s needed, whatever it takes. Maintaining the same dedicated project team over time helps our clients to build lasting relationships with a partner whom they trust. When our clients work with us, they stay with us – we have worked with 8 of our top 10 customers for more than 5 years.

1 Tubney Warren Barns, Tubney, Oxfordshire, OX13 5QJ, United Kingdom

- PMLiVE- PMLiVE

- PMLiVE

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.

HealthScience communications consultancy wins King’s Award

Oxford PharmaGenesis, the global HealthScience communications consultancy, was honoured on Friday 7 July, by a visit from King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM.

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

Oxford PharmaGenesis wins King’s Award following rapid export growth

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country.

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022

It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds...

ALL PRESS RELEASES

Let’s explore new frontiers

Our mission: helping patients in areas of unmet medical need

ALL VIDEOS AND PODCASTS

Our charity work is driven by our colleagues and supported by all levels of the company and a company budget. Together we fundraise for initiatives which are working towards the betterment of health, people and/or society. Each Oxford PharmaGenesis office has its own charity team who coordinated a bottom-up approach to fundraising events in their respective office and across the wider company. These representatives also advocate the company’s matched funding scheme, which supports colleagues in their fundraising activities by matching their fundraising goals.

Jill Wund

Jill Wund
Business Director, US

Richard White

Richard White
Chief Operating Officer

Chris Winchester

Chris Winchester
Chief Executive Officer

Company Details

- PMLiVE

Email
Website

 Latest Content from  Oxford PharmaGenesis 

ACCORD: new guideline to support consistent and complete reporting of consensus methods in biomedical research

Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies.

HealthScience communications consultancy wins King’s Award

Oxford PharmaGenesis, the global HealthScience communications consultancy, was honoured on Friday 7 July, by a visit from King Charles III’s representative in Oxfordshire, Lord-Lieutenant Marjorie Glasgow BEM.

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the third year running

We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.

Oxford PharmaGenesis wins King’s Award following rapid export growth

Oxford PharmaGenesis has been honoured with the first ever King’s Award for Enterprise, the most prestigious business award in the country.

Pharmaceutical companies reduce own greenhouse gas emissions, but action on supply chains needed

DPhil student, Dr Amy Booth (University of Oxford) and Oxford PharmaGenesis CEO, Dr Chris Winchester, have co-authored a new study published in the International Journal of Environmental Research and Public...

Let’s explore new frontiers

Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022

It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds...

Our mission: helping patients in areas of unmet medical need